SPTX

Latest SEC Filings & News for SPTX

2 most recent filings and news items mentioning SPTX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/SPTX/news?limit=20"

Pull SPTX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 3, 2026Positive

Seaport Therapeutics reports Q2 2026 results and clinical progress

The company announced full enrollment in its BUOY-1 Phase 2b trial of GlyphAllo for MDD and shared financial highlights, advancing its pipeline of neuropsychiatric therapies.

View filing at SEC.gov →

EarningsJun 8, 2026Positive

Seaport Therapeutics Reports Q1 2026 Results, $260M IPO Proceeds

Seaport Therapeutics reported Q1 2026 financial results and announced new Phase 1 data for GlyphAgo showing therapeutic exposures without liver enzyme elevation concerns. The company's recent upsized IPO generated $260M in gross proceeds, providing funding runway into 2029 while

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.